Target Details
| UniProt AC | P22607 |
|---|---|
| Gene Symbol | FGFR3 |
| Protein Name | Fibroblast growth factor receptor 3 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF21165 (FGFR3_TM) PF07679 (I-set) PF13927 (Ig_3) PF07714 (PK_Tyr_Ser-Thr) |
Summary
- Multi-target molecules 2,742
- Clinical molecules 64
- Avg pChEMBL 7.75
KEGG Pathways (13)
- Bladder cancer
- Calcium signaling pathway
- Central carbon metabolism in cancer
- EGFR tyrosine kinase inhibitor resistance
- Endocytosis
- MAPK signaling pathway
- MicroRNAs in cancer
- PI3K-Akt signaling pathway
- Pathways in cancer
- Rap1 signaling pathway
- Ras signaling pathway
- Regulation of actin cytoskeleton
- Signaling pathways regulating pluripotency of stem cells
Associated Diseases (15)
- Achondroplasia
- Bladder cancer
- CATSHL syndrome
- Colorectal cancer
- Crouzon syndrome
- Epidermal nevus
- FGFR3-related short limb skeletal dysplasia
- Hypochondroplasia
- Lacrimo-auriculo-dento-digital syndrome
- Muenke syndrome
- Multiple myeloma
- SADDAN
- Syndromic craniosynostoses
- Testicular cancer
- Thanatophoric dysplasia
Active Molecules (2,742)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
SUYFSSVDPYUJOM
|
8.9 | IC50 | 2 | — | |
YCIJEVLNRAYXFR
|
8.9 | IC50 | 2 | — | |
FPTHHDCUCCRNNU
|
8.9 | IC50 | 2 | — | |
HNVRKBGXTRVLEI
|
8.9 | IC50 | 5 | — | |
CYHGHBQCTXVJCN
|
8.8 | IC50 | 3 | — | |
FMYCPNBASOLHNV
|
8.8 | IC50 | 2 | — | |
MQABPWIBJWWDIM
|
8.8 | IC50 | 2 | — | |
PZUMGJXNMDBEIT
|
8.8 | IC50 | 2 | — | |
QWKBMCGLZANBBQ
|
8.8 | IC50 | 2 | — | |
UQZPQFKVJWOQTM
|
8.8 | IC50 | 4 | — | |
WXRBLSQWDTUDCY
|
8.8 | IC50 | 2 | — | |
FBJRJSLJQISKRR
|
8.8 | IC50 | 5 | — | |
HCDMJFOHIXMBOV
|
8.8 | IC50 | 4 | — | |
JYZXTSDUMOPSSZ
|
8.8 | Kd | 3 | — | |
OCBQEYMCTIONEB
|
8.8 | IC50 | 2 | — | |
OCBQEYMCTIONEB
|
8.8 | IC50 | 2 | — | |
YASHODHUWYIHDK
|
8.8 | IC50 | 5 | — | |
DYYHERDJUMIWAW
|
8.8 | IC50 | 2 | — | |
IBSMXTBTUWUZJT
|
8.8 | IC50 | 2 | — | |
MQTVDWCDNQKMHP
|
8.8 | Kd | 3 | — | |
ROOGKKMRYAUSLO
|
8.8 | IC50 | 3 | — | |
YJAREBGBTVFDIK
|
8.8 | IC50 | 5 | — | |
FVUYKZNGSHSNBI
|
8.8 | IC50 | 5 | — | |
FXIBXFGZSDZFSP
|
8.8 | IC50 | 5 | — | |
GEVGLUZEQGOXES
|
8.8 | IC50 | 2 | — | |
QPILVXXWABVBBV
|
8.8 | IC50 | 5 | — | |
DOZFKJVXGLERIQ
|
8.8 | IC50 | 3 | — | |
HAMQGTWNMUEACH
|
8.8 | IC50 | 5 | — | |
HEAOOEBHFBBENP
|
8.8 | IC50 | 3 | — | |
NHVRJDXWYOYVDB
|
8.8 | IC50 | 3 | — | |
NYEZHXSUIICMSA
|
8.8 | IC50 | 5 | — | |
ORRNXKQJDVQOSK
|
8.8 | IC50 | 5 | — | |
OWRXHGAFWZFFCW
|
8.8 | Ki | 113 | — | |
RIDLANJMTSBUSD
|
8.8 | IC50 | 5 | — | |
VCIZYTQJDGPPDJ
|
8.8 | IC50 | 6 | — | |
SPYAVYXITOMQDI
|
8.8 | IC50 | 2 | — | |
UHPWIGXTFQRPCG
|
8.8 | IC50 | 5 | — | |
YRIBONQFXXVSAU
|
8.8 | IC50 | 5 | — | |
YWXPUULEEPYBOI
|
8.8 | IC50 | 2 | — | |
CYWDLLRCEFUKME
|
8.8 | IC50 | 3 | — | |
LABBTNAJUXRSJY
|
8.8 | IC50 | 3 | — | |
LKMLECIRYJPQOC
|
8.8 | IC50 | 5 | — | |
USCLDZNWLVHDPF
|
8.8 | IC50 | 5 | — | |
VJRPDSCCZRPRJC
|
8.8 | IC50 | 4 | — | |
XAJGMXLLRBDBQT
|
8.8 | IC50 | 3 | — | |
DCZBPNBODJYQFH
|
8.8 | IC50 | 2 | — | |
IEZSYOTXLDGZAI
|
8.8 | Kd | 3 | — | |
JEBDREWJGILFIZ
|
8.8 | IC50 | 3 | — | |
JWBKKCJZIDXHLG
|
8.8 | IC50 | 3 | — | |
KDGIYEHYWASRCT
|
8.8 | IC50 | 2 | — |